{
  "id": "mhgap#screening_cues_facd874c",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 16. Global alcohol action plan 2022–2030: 23. Atlas: country resources for neurological disorders, second draft, unedited. Geneva: World Health 2nd edition. Geneva: World Health Organization; Organization; 2021 (https://www.who.int/ 2017 (https://iris.who.int/handle/10665/258947). publications/m/item/global-alcohol-action-plan- 24. Mental health atlas 2020. Geneva: World second-draft-unedited). Health Organization; 2021 (https://iris.who.int/ 17. Declarations of interest. In: World Health handle/10665/345946). Organization [website]. Geneva: World Health 25. Agabio R, Saulle R, Rösner S, Minozzi S. Baclofen Organization; 2020 (https://www.who.int/ for alcohol use disorder. Cochrane Database Syst about/ethics/declarations-of-interest, accessed Rev. 2023;(1):CD012557. 27 September 2023). 26. The ICD-10 classification of mental and 18. Alonso-Coello P, Schünemann HJ, Moberg J, behavioural disorders: diagnostic criteria for Brignardello-Petersen R, Akl EA, Davoli M et al. research. Geneva: World Health Organization; 1993 GRADE Evidence to Decision (EtD) frameworks: a (https://iris.who.int/handle/10665/37108). systematic and transparent approach to making well informed healthcare choices. 1: Introduction. 27. American Psychiatric Association. Diagnostic and BMJ. 2016;353:i2016 (http://dx.doi.org/10.1136/ statistical manual of mental disorders: DSM-IV. bmj.i2016). Washington (DC): American Psychiatric Publishing; 1994. 19. Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S et al. Treatment gap 28. ICD-11: International Classification of Diseases for anxiety disorders is global: results of the 11th Revision [website]. Geneva: World Health World Mental Health Surveys in 21 countries. Organization; 2019 (https://icd.who.int/, accessed Depress Anxiety. 2018;35(3):195–208 (https://doi. 19 October 2023). org/10.1002/da.22711). 29. American Psychiatric Association, DSM-5 Task 20. Porritt K, Gomersall J, Lockwood C. JBI’s Force. Diagnostic and statistical manual of mental systematic reviews: study selection and critical disorders: DSM-5, 5th edition. Arlington (VA): appraisal. Am J Nurs. 2014;114(6):47–52 (https:// American Psychiatric Publishing; 2013 (https://doi. doi.org/10.1097/01.NAJ.0000450430.97383.64). org/10.1176/appi.books.9780890425596). 21. Lewin S, Booth A, Glenton C, Munthe-Kaas 30. Sundström C, Blankers M, Khadjesari Z. Computer- H, Rashidian A, Wainwright M et al. Applying based interventions for problematic alcohol GRADE-CERQual to qualitative evidence synthesis use: a review of systematic reviews. Int J Behav findings: introduction to the series. Implement Med. 2017;24(5):646–58 (https://doi.org/10.1007/ Sci. 2018:13(Suppl 1):2 (https://doi.org/10.1186/ s12529-016-9601-8). s13012-017-0688-3). 31. WHO guideline: recommendations on digital 22. Lewin S, Glenton C, Lawrie TA, Downe S, interventions for health system strengthening: Finlayson KW, Rosenbaum S et al. Qualitative evidence and recommendations. Geneva: World evidence synthesis (QES) for guidelines: paper Health Organization; 2019 (https://iris.who.int/ 2 – using qualitative evidence synthesis findings handle/10665/311980). to inform evidence-to-decision frameworks 32. Agabio R, Camposeragna A, Saulle R, Krupchanka and recommendations. Health Res Policy Syst. D, Leggio L, Minozzi S. Combined pharmacological 2019;17(1):75 (https://doi.org/10.1186/s12961-019- and psychosocial interventions for alcohol 0468-4). use disorder. Cochrane Database Syst Rev. 2023;(3):CD015673. 116 References 33. Chawla N, Anothaisintawee T, 40. Pauley D, Cuijpers P, Papola D, Miguel C, Karyotaki Charoenrungrueangchai K, Thaipisuttikul P, E. Two decades of digital interventions for Mckay GJ, Attia J et",
  "gloss_vi": "Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders 16. global alcohol action plan 2022–2030: 23.",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "referral",
      "management"
    ],
    "life_topics": [
      "study",
      "work"
    ],
    "advice_section": [
      "work_habits"
    ],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 16. Global alcohol action plan 2022–2030: 23. Atlas: country resources for neurological disorders, second draft, unedited. Geneva: World Health 2nd edition. Geneva: World Health Organization; Organization; 2021 (https://www.who.int/ 2017 (https://iris.who.int/handle/10665/258947). publications/m/item/global-alcohol-action-plan- 24. Mental health atlas 2020. Geneva: World second-draft-unedited). Health Organization; 2021 (https://iris.who.int/ 17. Declarations of interest. In: World Health handle/10665/345946). Organization [website]. Geneva: World Health 25. Agabio R, Saulle R, Rösner S, Minozzi S. Baclofen Organization; 2020 (https://www.who.int/ for alcohol use disorder. Cochrane Database Syst about/ethics/declarations-of-interest, accessed Rev. 2023;(1):CD012557. 27 September 2023). 26. The ICD-10 classification of mental and 18. Alonso-Coello P, Schünemann HJ, Moberg J, behavioural disorders: diagnostic criteria for Brignardello-Petersen R, Akl EA, Davoli M et al. research. Geneva: World Health Organization; 1993 GRADE Evidence to Decision (EtD) frameworks: a (https://iris.who.int/handle/10665/37108). systematic and transparent approach to making well informed healthcare choices. 1: Introduction. 27. American Psychiatric Association. Diagnostic and BMJ. 2016;353:i2016 (http://dx.doi.org/10.1136/ statistical manual of mental disorders: DSM-IV. bmj.i2016). Washington (DC): American Psychiatric Publishing; 1994. 19. Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S et al. Treatment gap 28. ICD-11: International Classification of Diseases for anxiety disorders is global: results of the 11th Revision [website]. Geneva: World Health World Mental Health Surveys in 21 countries. Organization; 2019 (https://icd.who.int/, accessed Depress Anxiety. 2018;35(3):195–208 (https://doi. 19 October 2023). org/10.1002/da.22711). 29. American Psychiatric Association, DSM-5 Task 20. Porritt K, Gomersall J, Lockwood C. JBI’s Force. Diagnostic and statistical manual of mental systematic reviews: study selection and critical disorders: DSM-5, 5th edition. Arlington (VA): appraisal. Am J Nurs. 2014;114(6):47–52 (https:// American Psychiatric Publishing; 2013 (https://doi. doi.org/10.1097/01.NAJ.0000450430.97383.64). org/10.1176/appi.books.9780890425596). 21. Lewin S, Booth A, Glenton C, Munthe-Kaas 30. Sundström C, Blankers M, Khadjesari Z. Computer- H, Rashidian A, Wainwright M et al. Applying based interventions for problematic alcohol GRADE-CERQual to qualitative evidence synthesis use: a review of systematic reviews. Int J Behav findings: introduction to the series. Implement Med. 2017;24(5):646–58 (https://doi.org/10.1007/ Sci. 2018:13(Suppl 1):2 (https://doi.org/10.1186/ s12529-016-9601-8). s13012-017-0688-3). 31. WHO guideline: recommendations on digital 22. Lewin S, Glenton C, Lawrie TA, Downe S, interventions for health system strengthening: Finlayson KW, Rosenbaum S et al. Qualitative evidence and recommendations. Geneva: World evidence synthesis (QES) for guidelines: paper Health Organization; 2019 (https://iris.who.int/ 2 – using qualitative evidence synthesis findings handle/10665/311980). to inform evidence-to-decision frameworks 32. Agabio R, Camposeragna A, Saulle R, Krupchanka and recommendations. Health Res Policy Syst. D, Leggio L, Minozzi S. Combined pharmacological 2019;17(1):75 (https://doi.org/10.1186/s12961-019- and psychosocial interventions for alcohol 0468-4). use disorder. Cochrane Database Syst Rev. 2023;(3):CD015673. 116 References 33. Chawla N, Anothaisintawee T, 40. Pauley D, Cuijpers P, Papola D, Miguel C, Karyotaki Charoenrungrueangchai K, Thaipisuttikul P, E. Two decades of digital interventions for Mckay GJ, Attia J et Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders 16. global alcohol action plan 2022–2030: 23."
}